HRMY
Price
$33.56
Change
-$2.27 (-6.34%)
Updated
Sep 9, 02:38 PM (EDT)
Capitalization
2.06B
56 days until earnings call
MTX
Price
$62.64
Change
-$1.53 (-2.38%)
Updated
Sep 9, 02:43 PM (EDT)
Capitalization
2.01B
44 days until earnings call
Interact to see
Advertisement

HRMY vs MTX

Header iconHRMY vs MTX Comparison
Open Charts HRMY vs MTXBanner chart's image
Harmony Biosciences Holdings
Price$33.56
Change-$2.27 (-6.34%)
Volume$100
Capitalization2.06B
Minerals Technologies
Price$62.64
Change-$1.53 (-2.38%)
Volume$170
Capitalization2.01B
HRMY vs MTX Comparison Chart in %
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. MTX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a Hold and MTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (HRMY: $35.83 vs. MTX: $64.17)
Brand notoriety: HRMY and MTX are both not notable
HRMY represents the Biotechnology, while MTX is part of the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: HRMY: 179% vs. MTX: 116%
Market capitalization -- HRMY: $2.06B vs. MTX: $2.01B
HRMY [@Biotechnology] is valued at $2.06B. MTX’s [@Chemicals: Specialty] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $222.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Chemicals: Specialty] industry is $9.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileMTX’s FA Score has 1 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • MTX’s FA Score: 1 green, 4 red.
According to our system of comparison, HRMY is a better buy in the long-term than MTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 4 TA indicator(s) are bullish while MTX’s TA Score has 4 bullish TA indicator(s).

  • HRMY’s TA Score: 4 bullish, 4 bearish.
  • MTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both HRMY and MTX are a good buy in the short-term.

Price Growth

HRMY (@Biotechnology) experienced а -2.87% price change this week, while MTX (@Chemicals: Specialty) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.58%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +35.43%.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -0.22%. For the same industry, the average monthly price growth was +3.86%, and the average quarterly price growth was +11.93%.

Reported Earning Dates

HRMY is expected to report earnings on Nov 04, 2025.

MTX is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+1.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Chemicals: Specialty (-0.22% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($2.06B) and MTX($2.01B) have the same market capitalization . MTX has higher P/E ratio than HRMY: MTX (6417.00) vs HRMY (11.56). HRMY YTD gains are higher at: 4.127 vs. MTX (-15.362). HRMY has higher annual earnings (EBITDA): 265M vs. MTX (159M). HRMY has more cash in the bank: 565M vs. MTX (320M). HRMY has less debt than MTX: HRMY (172M) vs MTX (983M). MTX has higher revenues than HRMY: MTX (2.06B) vs HRMY (773M).
HRMYMTXHRMY / MTX
Capitalization2.06B2.01B102%
EBITDA265M159M167%
Gain YTD4.127-15.362-27%
P/E Ratio11.566417.000%
Revenue773M2.06B37%
Total Cash565M320M177%
Total Debt172M983M17%
FUNDAMENTALS RATINGS
MTX: Fundamental Ratings
MTX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYMTX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 2 days ago
65%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 6 days ago
64%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVWSX28.06N/A
N/A
Fidelity Series Opportunistic Insights
AMGAX17.91N/A
N/A
Alger Mid Cap Growth A
PABAX17.17N/A
N/A
Putnam Dynamic Asset Allocation Bal A
QMGRX12.73N/A
N/A
Invesco Advantage International R
HAOSX16.00N/A
N/A
Harbor International Core Institutional

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-0.44%
SNBIF - HRMY
52%
Loosely correlated
N/A
CYTK - HRMY
37%
Loosely correlated
-1.74%
ANAB - HRMY
36%
Loosely correlated
+1.39%
AXON - HRMY
31%
Poorly correlated
+1.67%
LGND - HRMY
31%
Poorly correlated
-0.48%
More

MTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTX has been closely correlated with IOSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTX jumps, then IOSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTX
1D Price
Change %
MTX100%
+0.09%
IOSP - MTX
71%
Closely correlated
-0.61%
SCL - MTX
68%
Closely correlated
-0.24%
AVNT - MTX
67%
Closely correlated
+0.37%
OLN - MTX
64%
Loosely correlated
-1.11%
PPG - MTX
64%
Loosely correlated
+1.41%
More